Harold Hatch
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer
- Fibroblast Growth Factor Research
- Inflammasome and immune disorders
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 3
-
- Calpain Protease Function and Regulation 1
- Co-authors
- Bo‐Sheng Pan (4 shared papers)Pradip K. Majumder (2 shared papers)Yoko Ueno (1 shared paper)Hiroshi Sootome (1 shared paper)Shunsuke Taguchi (1 shared paper)Katsuyoshi Miyama (1 shared paper)Yoko Nakatsuru (1 shared paper)Hidehito Kotani (1 shared paper)
- Journals
- Cancer Research (3 papers)Analytical Biochemistry (1 paper)Molecular Cancer Therapeutics (1 paper)Journal of Investigative Dermatology (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Harold Hatch
7 papers receiving 1.4k citations
Harold Hatch's Hit Papers
Peers
Comparison fields: 5 of 78
- Hepatology 138
- Molecular Biology 982
- Oncology 302
- Cancer Research 148
- Pathology and Forensic Medicine 155
Countries citing papers authored by Harold Hatch
This map shows the geographic impact of Harold Hatch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold Hatch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold Hatch more than expected).
Fields of papers citing papers by Harold Hatch
This network shows the impact of papers produced by Harold Hatch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold Hatch. The network helps show where Harold Hatch may publish in the future.
Co-authors
The 25 scholars most cited alongside Harold Hatch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo Hit paper breakdown → | 2010 | 769 |
| 2 | 2007 | 261 | |
| 3 | 2008 | 232 | |
| 4 | 2018 | 145 | |
| 5 | 2002 | 24 | |
| 6 | 2011 | 15 | |
| 7 | Abstract #3714: In vitro and in vivo antitumor activities of MK-2206, a new allosteric Akt inhibitor | 2009 | 11 |
About Harold Hatch
Harold Hatch is a scholar working on Molecular Biology, Cell Biology, Pulmonary and Respiratory Medicine, Infectious Diseases and Organic Chemistry, having authored 7 papers that have together received 1.5k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Mechanisms and Therapy (1 paper), Meat and Animal Product Quality (1 paper), Liver physiology and pathology (1 paper), Quinazolinone synthesis and applications (1 paper), Mosquito-borne diseases and control (1 paper) and Calpain Protease Function and Regulation (1 paper). The work is most often cited by research in Hepatology (138 citations), Molecular Biology (982 citations), Oncology (302 citations), Cancer Research (148 citations) and Pathology and Forensic Medicine (155 citations). Harold Hatch has collaborated with scholars based in United States and Japan. Frequent co-authors include Bo‐Sheng Pan, Pradip K. Majumder, Yoko Ueno, Hiroshi Sootome, Shunsuke Taguchi, Katsuyoshi Miyama, Yoko Nakatsuru, Hidehito Kotani, Hiroshi Hirai and Lenora J. Davis. Their work appears in journals such as Cancer Research, Analytical Biochemistry, Molecular Cancer Therapeutics, Journal of Investigative Dermatology and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.